DOCSLIB.ORG

World-First Approach to Fighting Hiv

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

THE NEWSLETTER OF THE BURNET INSTITUTE | AUTUMN 2013 PNG: TACKLING TUBERCULOSIS HEALTH IN CHINA: A NEW CHAPTER WORLD-FIRST APPROACH TO FIGHTING HIV burnet.edu.au DIRECTOR’S REPORT INSIDE FEATURES elcome to the Autumn issue of IMPACT. At the time of writing 3 PHILANTHROPY IN ACTION this I have just returned from an important visit to Myanmar 6 RUSHING TOWARDS A CURE (Burma). Together with Board colleagues, Chairman Alastair Lucas AM and Board member, Natasha Stott Despoja AM, I had the 8 TACKLING TUBERCULOSIS IN PNG privilege of meeting with Burnet’s program sta!, visiting our women’s and children’s health projects and meeting with high-level government 10 HEALTH IN CHINA o"cials, including the Health Minister, Dr Pe Thet Khin and opposition 12 ADVANCES IN THE FIGHT leader, Aung San Suu Kyi. Discussions were very positive and centred AGAINST HIV on Burnet’s contribution to improving health systems, especially post 14 NEWS IN BRIEF Cyclone Nargis. The Institute has been working in Myanmar for more than 10 years and it is our largest international health program. Burnet is one of the few Australian non-government FRONT COVER IMAGE: organisations to be in this country for this length of time. Myanmar as most of you would be A stylised illustration of HIV. aware is changing quickly, the political situation has eased somewhat, and the move towards Burnet Institute is an a democracy is rapidly taking place. With this change, comes the capacity for organisations Australian not-for-pro!t, such as Burnet to provide support to address many of the health issues facing the country; unaligned and independent especially the high rate of deaths among women during childbirth and that of their newborn organisation whose purpose babies. Your support of our Myanmar projects through the recent Christmas Appeal was most is to improve the health generous and I want to thank you for that, without it, we are unable to progress many of the of disadvantaged, poor or priority projects Burnet has on its agenda. otherwise vulnerable people This year will be one of signi#cance for medical research in Australia. The #nal report from throughout the world. the government-commissioned McKeon Review into medical research has been released by the Federal Government. It provides a ten-year strategic platform for how medical research should be approached. Positive reform like this is crucial to our sector. These are challenging economic times and in my roles as Burnet Director and as President of the Association of Australian Medical Research Institutes, much of my focus has been on creating awareness across the political spectrum that medical research is essential for better health. There has emerged a strong consensus on this but it also needs to be understood that living longer, better and more productive lives makes strong economic sense. This won’t happen without a strong, vibrant and relevant medical research and public health community. This issue of IMPACT discusses some of the key aspects of Burnet’s work in the areas of HIV and tuberculosis as well as taking a look at our work in China. I hope you enjoy reading this issue and look forward to sharing more about the Institute with you in the coming months. Best wishes, Professor Brendan Crabb, Director and CEO All donations over $2 are !lly tax deductible. Where possible people who appear in images included in this newsletter were photographed with their permission. There is no implication that these people have any infectious diseases. If you would like to discuss any issue from this edition of the Burnet Institute’s newsletter, IMPACT, please call Paul Rathbone on 03 9282 2113. Photo Credits: AusAID, Alex Bernardin – San Francisco AIDS Foundation, Casey Budesilich, Gillian Chamberlain, Marcus Flack – Liquid Creations, Soe Lin Htut, Stephanie Luketic, Emma McBryde, Chris Morgan, Lisa Renkin, Paul Scott, Catherine Somerville, Doug Toerge – Magnet, Corey Wright. Managing Editor: Gillian Chamberlain. Design: Kelly Watson Design. 2 IMPACT Autumn 2012 PHILANTHROPY IN ACTION TECHNOLOGY TO CHANGE THE WORLD APPEAL SMALL TECHNOLOGY —BIG IMPACT Dear supporter of the Institute, The #rst specimens of the test are currently being produced, with a In a few days, a very important letter will reach you. It will tell the story view to undertake clinical trials over the coming months. This is where of Burnet’s revolutionary HIV diagnostic test, a world-#rst that could you can help. We need your support to bring the test from bench to change the lives of millions of people living with HIV worldwide. bedside and ensure that those who need it the most can e!ectively Nine years ago, Burnet took on the challenge of developing a use it. simple HIV diagnostic test. The test was designed to quickly measure The letter you will receive shortly will give you the chance to send a the number of a particular white cell in the blood known as CD4, gi& that will help us do just that. But if it is more convenient, you can which is an indicator of when patients should commence therapy. donate now using the coupon inside this newsletter. Current CD4 tests rely on %ow-cytometry, a complex application Many thanks for your support. widely available in the developed world, but of limited value for poor and vulnerable communities with restricted access to clinics and lab equipment. The inadequacy of the current technology means that millions of people lack appropriate access to therapy. Professor Brendan Crabb, Many hurdles later we have almost reached the #nish line. Director and CEO, Burnet Institute THANK YOU VERY MUCH! We recently caught up with two bene#ciaries of your support who asked us to share their heartfelt messages of thanks. Thank you from the lab Thank you from Myanmar To my great excitement, Burnet took possession of its #rst super- Your support means that we will be able to train 540 health workers resolution microscope a few weeks ago. The microscope will enable and midwives by the end of 2013, upgrade local health facilities, and scientists like me to capture images of human cells and infectious buy basic equipment and medicines essential for the care of mothers microbes in unprecedented detail for the #rst time in our scienti#c in Myanmar. careers. We would not have been able to purchase this incredible I was incredibly touched to learn that more than $50,000 has been machine without your support. Thank you so much for making this raised towards our mothers’ and children’s programs. Money goes a long dream a reality! way in countries like Myanmar, and your support will de#nitely change Dr Candida da Fonsesca Pereira, lives. I can assure you that your gi& will be used with all our deliberate Head, Burnet’s Cell Imaging Facility energy to improve the lot of those who need it most. Thank you! Dr Karl Dorning, Myanmar Country Representative IMPACT Autumn 2013 3 PHILANTHROPY IN ACTION INTERNATIONAL WOMEN’S DAY Burnet researcher Eman Aleksic chats with guest Kath Cunningham. Keynote address by Professor Suzanne Crowe AM. Burnet Institute’s and bequestors, researchers presentation by four Burnet Margaret Hellard on the critical International Women’s Day and students from across the scientists who spoke about importance of health education, luncheon celebrated the Institute, and representatives their research: Dr Freya especially among young people. Institute’s achievements in from charitable trusts and Fowkes on malaria in pregnant The women and supporters women’s health. other organisations that women; Associate Professor of Burnet take pride in our support Burnet’s work in Gilda Tachedjian on the contribution to public health, Burnet Associate Director, women’s health. development of microbicides and to social justice at a global Professor Suzanne Crowe AM Taking the theme and the prevention of HIV in level, and this was evident in the hosted the event, speaking ‘Empowering Women through women; Dr Claire Ryan on the warmth and enthusiasm at this to women from all reaches of Health Knowledge’, Professor human papillomavirus in Papua wonder'l celebration. the Burnet family: supporters Crowe was joined in her New Guinea; and Professor SHARE YOUR GOOD FORTUNE WITH BURNET Make a donation through ShareGi& Australia Do you have a small, initiative which can bene#t sale of shares on market, free For 'rther information, unmarketable parcel of shares Burnet’s medical research and of brokerage/GST costs and see the ShareGi& website that you would like to put to public health work, at no cost donates 100 per cent of the sharegi&australia.org.au work to improve the health of to you and in a tax e!ective way cash proceeds to Australian or download the donation disadvantaged and vulnerable – through ShareGi& Australia. charities. Donations of shares form from the Burnet website people in Australia and There are no brokerage fees valued more than $2 are burnet.edu.au/support_our_work throughout the world? and you can nominate the tax deductible. To discuss including a If so, ShareGi& Australia can Burnet Institute as a bene#ciary Any number of shares can bequest of shares in your Will, make the process very easy of ShareGi& distributions. be sold in actively trading please contact our Planned for you. ShareGi& Australia is an ASX listed companies through Giving Manager, Merrilyn Your small share parcel independent, non-pro#t ShareGi&. Even one share can Julian on (03) 8506 2338 or can now be easily sold via an organisation that arranges the make a di!erence. email [email protected] 4 IMPACT Autumn 2013 PHILANTHROPY IN ACTION A GIFT OF LIFE FOR THOSE SUFFERING FROM TUBERCULOSIS Every day 4,000 people lose their lives to tuberculosis (TB).
Recommended publications
  • Download the Burnet/360Biolabs Media Release

    Download the Burnet/360Biolabs Media Release

    MEDIA RELEASE 16 August 2021 Transformational day for Burnet with the sale of 360biolabs Melbourne, Victoria: The Burnet Institute majority owned company 360biolabs has signed an agreement to be purchased by BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on large molecule drug development and bioanalysis. Headquartered in North Carolina, USA, BioAgilytix Labs also has laboratories in Boston, and Hamburg, Germany. While the precise purchase price remains commercial-in-confidence, the sale will mean several hundred million dollars in revenue for Burnet, more than tripling our current corpus. The acquisition is subject to Australian Foreign Investment Review Board (“FIRB”) requirements and is expected to be complete in the third quarter of 2021. Burnet Institute Director and CEO, Professor Brendan Crabb AC said it was a transformational achievement for the Institute and welcomed the visionary strategic focus of BioAgilytix to build on 360biolabs’ world-class virology and immunology expertise. “Burnet Institute is proud of its involvement in the foundation of 360biolabs. It is the right time, with the growing need for high quality clinical trial support, for a company of the scale, capability, and reputation of 360biolabs to join with BioAgilytix and expand their capacity to service their customers and facilitate high quality translational medical research,” Professor Crabb said. With science playing such a leading role in the COVID-19 global pandemic response, Professor Crabb said the sale was another remarkable success story, not only for the Institute and the 360biolabs team, but also for showcasing the importance of ongoing support by Victorian and Federal governments in investing heavily in the world renown medical research sector in Melbourne and throughout Australia.
  • The Australian Democrats Andrew Bartlett*

    The Australian Democrats Andrew Bartlett*

    Australian Cultural History Vol. 27, No.2, October 2009, 187-193 The Australian Democrats Andrew Bartlett* The Australian Democrats had maintained a presence in the Senate since 1977, but the 2007 election threatened to end their representation for good. Their efforts to retain seats proved to be in vain. Keywords: 2007 election; Australian Democrats; Senate Following on from the 2004 election, where the Australian Democrats lost four seats (including the Democrat seat Meg Lees had taken with her when she resigned from the party in 2002), plus official parliamentary status and balance of power in the Senate, the Party faced a very difficult task in the 2007 election trying to keep its four remaining Senate seats. Right throughout John Howard's fourth term, opinion polls showed public support for the Democrats consistently scraping along rock bottom levels of 1 or 2 per cent, as they had ever since the Lees resignation and the related public implosion of Natasha Stott Despoja's leadership in 2002. Even though the removal of the Democrats from the balance of power after the 2004 poll led directly to the Coalition government gaining control of the Senate, where it frequently used its majority to stifle scrutiny and bulldoze through some controversial legislation, the Democrats were unable to use this situation to build public support for returning the Party to its traditional Senate watchdog position. The Party had avoided going into debt in its 2004 campaign, so there were sufficient funds to run a basic campaign in priority areas for the 2007 election. However, serious use of paid advertising was not feasible.
  • 1 Heat Treatment This Is a List of Greenhouse Gas Emitting

    1 Heat Treatment This Is a List of Greenhouse Gas Emitting

    Heat treatment This is a list of greenhouse gas emitting companies and peak industry bodies and the firms they employ to lobby government. It is based on data from the federal and state lobbying registers.* Client Industry Lobby Company AGL Energy Oil and Gas Enhance Corporate Lobbyists registered with Enhance Lobbyist Background Limited Pty Ltd Corporate Pty Ltd* James (Jim) Peter Elder Former Labor Deputy Premier and Minister for State Development and Trade (Queensland) Kirsten Wishart - Michael Todd Former adviser to Queensland Premier Peter Beattie Mike Smith Policy adviser to the Queensland Minister for Natural Resources, Mines and Energy, LHMU industrial officer, state secretary to the NT Labor party. Nicholas James Park Former staffer to Federal Coalition MPs and Senators in the portfolios of: Energy and Resources, Land and Property Development, IT and Telecommunications, Gaming and Tourism. Samuel Sydney Doumany Former Queensland Liberal Attorney General and Minister for Justice Terence John Kempnich Former political adviser in the Queensland Labor and ACT Governments AGL Energy Oil and Gas Government Relations Lobbyists registered with Government Lobbyist Background Limited Australia advisory Pty Relations Australia advisory Pty Ltd* Ltd Damian Francis O’Connor Former assistant General Secretary within the NSW Australian Labor Party Elizabeth Waterland Ian Armstrong - Jacqueline Pace - * All lobbyists registered with individual firms do not necessarily work for all of that firm’s clients. Lobby lists are updated regularly. This
  • Annual Report | 2015

    Annual Report | 2015

    Annual Report 2015 Celebrating years 15 years of influence Mc Keon MRFF MRFF Research Wills Review Beyond Grant Review Global Threat of 10 Strategic Review created to Beyond proposed Australia funding Discovery Funding Financial $400m Imperatives recommends deliver extra Discovery II in Federal established doubles launched Doubles Crisis funding cut launched more research $1 billion Budget funding funding 900 NMHRC Annual Expenditure 2000 – 2015 800 Millions ($) 700 600 500 400 300 Howard Rudd – Gillard – Rudd Abbott – Turnbull 200 Government Government Government 100 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Research Australia Leadership Chair: Peter Wills Chair: Prof John Niland Chair: Chris Roberts CEO: Rebecca James Chair: Prof CEO: Elizabeth Vice Chancellor of UNSW Christine Foley CEO: Bev Dyke Bennett CEO: Dr Christine Bennett *Dr Jane Glatz was acting CEO part of 2002 Published November 2015 2 Chairman’s Foreword A reflection on 15 years Fifteen years ago, Peter Wills AC in his landmark report1 Research Australia has always valued the role a well-informed recommended the establishment of Research Australia – an and engaged community has in highlighting research as a alliance for discoveries in health to the then Prime Minister, priority for government and health. Campaigns such as ‘Thank John Howard, OM, AC and Health Minister, Dr Michael You Day’, ‘Cook For A Cure’ and, of course, our Research Australia Wooldridge. Based on Research!America the establishment Annual Awards Night have been powerful opportunities for of this new organisation brought together all aspects of “the telling the stories behind the great research and innovation.
  • Capital Punishment and Australian Foreign Policy

    Capital Punishment and Australian Foreign Policy

    POLICY BRIEF August 2006 DR MICHAEL FULLILOVE Capital Punishment and Program Director Global Issues Australian Foreign Policy Tel: +61 2 8238 9040 [email protected] W h a t i s t h e p r o b l e m ? Australia is an abolitionist country. Both the Australian Government and the Opposition are opposed to capital punishment. Australia engages in modest advocacy against the death penalty but most of Canberra’s efforts are directed toward cases involving Australian citizens. These are likely to continue to occur: our closest Asian neighbours retain the death penalty, and Australian nationals will probably continue to commit criminal acts carrying this penalty. Situations involving Australians often do violence to bilateral relations. For example, the looming execution of Van Tuong Nguyen last year led to calls from Australian commentators for trade and business sanctions against Singapore, and charges of hypocrisy being levelled against Australia in the regional press. The problem, then, is twofold: Australian diplomacy is making little progress toward universal abolition, a bipartisan national policy; and our bilateral relationships are being damaged because of our perceived hypocrisy on the issue. W h a t s h o u l d b e d o n e ? Australia is an effective advocate for our nationals on death row. However, we should accelerate our efforts on comprehensive abolition, in two ways: • Australian political leaders should bring some consistency to their rhetoric on the death penalty; and • Australia should initiate a regional coalition against capital punishment. In the past decade five Asian states have done away with the death penalty.
  • Australia: Professor Marian Simms Head, Political Studies Department

    Australia: Professor Marian Simms Head, Political Studies Department

    Australia: Professor Marian Simms Head, Political Studies Department University of Otago Paper prepared for presentation at the joint ANU/UBA ‘John Fogarty Seminar’, Buenos Aires, Argentina 26-27 April 2007 Please note this paper is a draft version and is not for citation at this stage 1 Overview: Australian has been characterized variously as ‘The Lucky Country’ (Donald Horne), ‘A Small Rich Industrial Country’ (Heinz Arndt), and as suffering from ‘The Tyranny of Distance’ (Geoffrey Blainey). These distinguished authors have all mentioned negatives alongside positives; for example, political commentator Donald Horne’s famous comment was meant to be ironic – Australia’s affluence, and hence stability, were founded on good luck via rich mineral resources. For Blainey, the historian, geography mattered, both in terms of the vast distances from Europe and in terms of the vast size of the country.1 For economic historian Arndt, size was a double-edged sword – Australia had done well in spite of its small population. Those commentatories were all published in the 1970s. Since then much has happened globally, namely the stock market crash of the eighties, the collapse of communism in the late eighties and early nineties, the emergence of the Asian tigers in the nineties, and the attack on New York’s twin towers in 2001. All were profound events. It is the argument of this paper that in spite of these and other challenges, Australia’s institutional fabric has incorporated economic, social and political change. This is not to say that it has solved all of its social and economic problems, especially those dealing with minority groups such as the indigenous community, disaffected youth and some immigrant groups.
  • Australian Scientists Make Breakthrough on HIV's Infectious

    Australian Scientists Make Breakthrough on HIV's Infectious

    Bioboard AUSTRALIA of proteins, called chemokines, that guide resting cells through the blood Look out for these and into lymph node tissue can upcoming Issues Australian Scientists Make ‘unlock the door’ and allow HIV to Breakthrough on HIV’s enter and set up a silent or ‘latent’ Infectious Grip infection.” Prof Lewin said understanding 2010 how the virus achieved this should Australian scientists revealed the most complete picture of the way speed up the development of new October Diagnostic Technology and more potent treatments for HIV, Revolution in China Human immunodeficiency virus (HIV) maintains its infectious grip that could possibly block the virus November Medicinal Plants on the body, pointing to new ways from establishing latency while also to combat it. targeting its more active presence in December Waste Watch The Melbourne-based research the body. has explained how the virus hides Professor Brendan Crabb, dormant versions of itself in a Director of the Burnet Institute, said reservoir of cells out of the reach of the breakthrough was a long time conventional treatments but still able coming and heralded the beginning to “wake up” in the future, posing a of a new chapter in the fight major hurdle to any total cure for against HIV and Acquired immune HIV. deficiency syndrome (AIDS). “We “Once HIV gets into these (the global scientific community) cells, the virus can then go to sleep,” have been working on HIV for close Co-Head of the Burnet Institute’s to 30 years and it’s really only now Center for Virology and Director that we’re beginning to see that a of The Alfred’s Infectious Diseases cure for HIV might be achievable Unit, Professor Sharon Lewin said.
  • Institute for Health Transformation Board

    Institute for Health Transformation Board

    Institute for Health Transformation Board Professor Owens is an Alfred Deakin Professor and Professor Julie Owens the Deputy Vice-Chancellor Research at Deakin University. Her role is to provide academic leadership to advance Deakin’s distinctive research and research training both nationally and internationally. This includes research development, industry-focused research and commercialisation and research promotion. Prior to her appointment in 2018, she was Pro Vice Chancellor Research Strategy at University of Adelaide. Her previous roles there also included Associate Dean Research in Faculties of Sciences and Health Sciences, Head of School of Paediatrics and Reproductive Health and Department of Physiology. Originally an ARC QEII Fellow and NHMRC Research Fellow, she continues to be engaged in research into pregnancy and early development and how exposures such as parental obesity, can programme the lifelong health of offspring, supported by various bodies, including NIH, NHMRC, ARC and others. Frances is a well-known and respected Ms Frances Diver healthcare leader in Victoria, having held senior leadership roles for more than 15 years. Having initially trained as a nurse and midwife, Frances has worked in a clinical setting in a number of metropolitan and regional hospitals across New Zealand and Australia. Frances joined the Department of Health and Human Services and was ultimately Deputy Secretary, Hospital and Health Service Performance, charged with the responsibility for the overall performance of the Victorian public health services, including service, quality and financial outcomes. Before joining Barwon Health as the CEO in April 2019, Frances was the CEO of the Country Fire Authority (CFA). For three decades, Todd Harper has led Todd Harper organisations dedicated to global public health and prevention, including Cancer Council Victoria, Quit Victoria and VicHealth.
  • Nov 15, 2019 Dr Boreham's Crucible

    Nov 15, 2019 Dr Boreham's Crucible

    Biotech Daily Friday November 15, 2019 Daily news on ASX-listed biotechnology companies * ASX, BIOTECH UP: ONCOSIL UP 20%; PROTEOMICS DOWN 4% * DR BOREHAM’S CRUCIBLE: USCOM * BURNET PROF BRENDAN CRABB $80k GSK, RESEARCH AUST GONG * PALLA RETAIL RIGHTS RAISES $10.1m; TOTAL $30.7m * PROTEOMICS ‘HEAVILY OVERSUBSCRIBED’ PLACEMENT RAISES $3m * ALLEGRA BEGINS SHEEP SR-HT-GAHNITE CERVICAL FUSION STUDY * PHYLOGICA, GENENTECH ANTI-MICROBIAL WORK CANCELLED * RESAPP, SANOFI WORK ON RESPIRATORY SMARTPHONE DIAGNOSTIC * DORSAVI STAFF CUTS, COSTS DOWN; POSSIBLE CAPITAL RAISE * AUSTRALIAN PATENT FOR OBJ BODYGUARD * ELIXINOL PLEADS SCHULTZ, JAPAN ISSUE TO ASX 17% FALL QUERY * NOVITA TELLS ASX: ‘NDIS NEWS PUBLISHED QUICKLY’ * HERAMED REQUESTS 2nd ASX PRICE QUERY TRADING HALT * CEO DR BEHRENBRUCH, ELK RIVER DILUTED TO 10% OF TELIX * GNOSIS, ANDREAS KLUGE DILUTED TO 10% OF TELIX * CEO PAUL RENNIE INCREASES, DILUTED TO 12% OF PARADIGM * ANTEO NAME CHANGE TO ANTEOTECH * RESPIRI: SMEDLEY CHAIR, BLAIR-HOLT OUT; BOARD SPILL WITHDRAWN MARKET REPORT The Australian stock market was up 0.87 percent on Friday November 15, 2019, with the ASX200 up 58.6 points to 6,793.7 points. Seventeen of the Biotech Daily Top 40 stocks were up, 13 fell, nine traded unchanged and one was untraded. Oncosil was the best, up three cents or 20 percent to 18 cents with 13.0 million shares traded. LBT climbed 12.9 percent; Cynata, Impedimed, Imugene and Osprey improved more than seven percent; Amplia, Paradigm and Volpara were up five percent or more; Alterity was up 4.35 percent; Clinuvel, Genetic Signatures, Patrys and Pro Medicus rose more than two percent; CSL and Mesoblast were up more than one percent; with Cochlear, Next Science and Polynovo up by less than one percent.
  • NEWSLETTER in This Issue…

    NEWSLETTER in This Issue…

    NEWSLETTER Issue No. 18 January 2008 In this issue…. Index Dear Network Participant, Page No. I hope that you have had a relaxing break over Christmas and that 2008 brings you every 1 In this issue…… success. As Lisa continues her maternity leave, I’ll be taking responsibility for the 2 Congratulations Newsletter for the next few months. 2 Conference News 2008 promises to be a busy and exciting year for parasitology, in general, and the Network 3 Grant Winners and the ASP, in particular, as planning for ICOPA and for life after the end of the 3 Network Researcher Exchange, Network’s current funding begins in earnest. Training and Travel Awards The Network Management Committee and the ASP Council will be discussing a variety of 3 Network Mentorship Scheme alternatives for how the Network may look in the future and I’ll report on these discussions at 4 The Network IT Initiative the ASP Annual General Meeting in July. 4 The Network Survey for 2007 Featured in this issue is a profile on Russ Hobbs, recent recipient of an ASP Fellowship, 4 Profile: and congratulations for some recent outstanding achievements by Terry Speed, Russ Hobbs Brian Cooke, Brendan Crabb, and David Jenkins……... 6 Announcement from the Drugs for Neglected Diseases Initiative (DNDi) As always, please don’t hesitate to provide feedback and supply us with news stories, 6 Positions Vacant: grant successes, job ads, notices of upcoming events etc etc. We plan to issue a Newsletter PhD Scholarships at: at least every 2 months this year. Macquarie University In the meantime, best wishes, Nick Massey University (Nick Smith, Convenor, ARC/NHMRC Burnet Institute & Monash University Research Network for Parasitology; [email protected]) We gratefully acknowledge the support of our Network Newsletter Sponsor, BioAustralis.
  • Localization and Functional Analysis of Plasmodium Falciparum Genes Pfl2550w and Pff0750w

    Localization and Functional Analysis of Plasmodium Falciparum Genes Pfl2550w and Pff0750w

    Loyola University Chicago Loyola eCommons Master's Theses Theses and Dissertations 2010 Localization and Functional Analysis of Plasmodium Falciparum Genes PFL2550w and PFF0750w Carolyn Jane Strobel Loyola University Chicago Follow this and additional works at: https://ecommons.luc.edu/luc_theses Part of the Molecular Biology Commons Recommended Citation Strobel, Carolyn Jane, "Localization and Functional Analysis of Plasmodium Falciparum Genes PFL2550w and PFF0750w" (2010). Master's Theses. 491. https://ecommons.luc.edu/luc_theses/491 This Thesis is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It has been accepted for inclusion in Master's Theses by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. Copyright © 2010 Carolyn Jane Strobel LOYOLA UNIVERSITY CHICAGO LOCALIZATION AND FUNCTIONAL ANALYSIS OF PLASMODIUM FALCIPARUM GENES PFL2550W AND PFF0750W A THESIS SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL IN CANDIDACY FOR THE DEGREE OF MASTER OF SCIENCE PROGRAM IN BIOLOGY BY CAROLYN J. STROBEL CHICAGO, IL AUGUST 2010 Copyright by Carolyn J. Strobel, 2010 All rights reserved. ACKNOWLEDGEMENTS I would like to thank my thesis advisor, Dr. Kim Williamson, for all her guidance and support in my research project and other work in the lab. Her knowledge and expertise in this field enabled me to learn so much about malaria, and her guidance and instruction truly helped me to grow as a scientist. I would also like to thank my committee members, Dr. Stefan Kanzok and Dr.
  • Provisions of the Greater Sunrise Unitisation Agreement Implementation Bill 2004 and the Customs Tariff Amendment (Greater Sunrise) Bill 2004

    Provisions of the Greater Sunrise Unitisation Agreement Implementation Bill 2004 and the Customs Tariff Amendment (Greater Sunrise) Bill 2004

    The Senate Economics Legislation Committee Provisions of the Greater Sunrise Unitisation Agreement Implementation Bill 2004 and the Customs Tariff Amendment (Greater Sunrise) Bill 2004 March 2004 © Commonwealth of Australia 2004 ISBN 0 642 71378 2 Printed by the Senate Printing Unit, Parliament House, Canberra. SENATE ECONOMICS LEGISLATION COMMITTEE CORE MEMBERS Senator George Brandis, Chair (Queensland, LP) Senator Ursula Stephens, Deputy Chair (New South Wales, CL) Senator Grant Chapman (South Australia, LP) Senator Andrew Murray (Western Australia, AD) Senator John Watson (Tasmania, LP) Senator Ruth Webber (Western Australia, ALP) SUBSTITUTE MEMBERS Senator Allison to replace Senator Murray for matters relating to the Resources portfolio Senator O'Brien to replace Senator Webber for matters relating to tourism Senator Ridgeway to replace Senator Murray for the committee’s consideration of the provisions of the Treasury Legislation Amendment (Professional Standards) Bill 2003 Senator Stott Despoja to replace Senator Murray for the committee's consideration of the provisions of the Greater Sunrise Unitisation Agreement Implementation Bill 2004 and the Customs Tariff Amendment (Greater Sunrise) Bill 2004 PARTICIPATING MEMBERS Senator the Hon Eric Abetz (Tasmania, LP) Senator the Hon Ronald Boswell (Queensland, NPA) Senator Bob Brown (Tasmania, AG) Senator Geoffrey Buckland (South Australia, ALP) Senator George Campbell (New South Wales, ALP) Senator Kim Carr (Victoria, ALP) Senator John Cherry (Queensland, AD) Senator Stephen Conroy (Victoria,